tiprankstipranks
Advertisement

SMIN - ETF AI Analysis

Compare

Top Page

SMIN

iShares MSCI India Small Cap ETF (SMIN)

Rating:60Neutral
Price Target:
SMIN, the iShares MSCI India Small Cap ETF, has a solid but not outstanding overall rating, reflecting a mix of strong growth stories and some weaker names in its portfolio. Strong contributors like Coforge, Embassy Office Parks REIT, APAR Industries, and Sona BLW support the fund with robust financial performance and generally positive technical trends, while weaker holdings such as Glenmark Pharmaceuticals, which faces profitability and liquidity challenges with bearish momentum, drag on the rating. The main risk factor is that many top holdings show signs of high or premium valuations and overbought technical signals, which could increase volatility and limit future upside.
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many sectors like financials, materials, health care, and industrials, which helps reduce the impact if any one industry struggles.
Strong Performers Among Top Holdings
Several of the largest positions, such as companies in banking, exchanges, metals, and auto components, have shown strong gains this year, supporting the fund’s overall results.
Targeted Exposure to Indian Small Caps
The fund offers focused access to India’s small-cap companies, which can benefit from the country’s long-term economic growth and domestic demand trends.
Negative Factors
High Expense Ratio
The ETF charges a relatively high fee, which can eat into returns over time compared with lower-cost funds.
Recent Weak Year-to-Date Performance
The fund’s overall performance so far this year has been weak, which may concern investors looking for steadier returns.
Concentrated Country Risk in India
With almost all assets invested in Indian stocks, the ETF is highly sensitive to economic, political, and currency developments in India.

SMIN vs. SPDR S&P 500 ETF (SPY)

SMIN Summary

The iShares MSCI India Small Cap ETF (SMIN) tracks the MSCI India Small Cap Index, which focuses on smaller companies in India that may have higher growth potential. It spreads your money across many sectors, including financials, materials, health care, and technology. Some of its better-known holdings include Federal Bank Ltd. and Glenmark Pharmaceuticals. An investor might choose SMIN to seek long-term growth and to diversify into India’s fast-growing economy. However, this fund invests in small, emerging companies, so its price can be very volatile and can go up and down sharply with the market.
How much will it cost me?The iShares MSCI India Small Cap ETF (SMIN) has an expense ratio of 0.75%, meaning you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because it is an actively managed fund focusing on small-cap stocks in India, which require more research and management compared to passively managed funds.
What would affect this ETF?The iShares MSCI India Small Cap ETF (SMIN) could benefit from India's strong economic growth and increasing innovation in sectors like technology and healthcare, which are key areas of exposure for the fund. However, risks include potential regulatory changes in India, global economic uncertainty, and the inherent volatility of small-cap stocks, which can be more sensitive to market fluctuations. Investors should also consider how interest rate changes or inflation could impact sectors like financials and consumer goods within the ETF.

SMIN Top 10 Holdings

SMIN’s story is all about India’s fast-moving small caps, with a tilt toward financials, healthcare, and industrial names. Recent strength from stocks like Laurus Labs, MCX, and Sona BLW has been giving the fund a helpful tailwind, while Federal Bank and Glenmark have been more of a speed bump, lagging in the near term. Coforge and KEI are holding steady to rising, but with some valuation jitters. With all its bets placed squarely in India, this ETF is a pure play on the country’s homegrown growth engines.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Laurus Labs Ltd.1.51%$9.85M₹750.67B109.03%
66
Neutral
Coforge Limited1.35%$8.81M₹598.71B-23.73%
73
Outperform
Max Financial Services Limited1.27%$8.23M₹538.91B3.42%
59
Neutral
Embassy Office Parks REIT1.14%$7.38M₹408.90B8.74%
76
Outperform
KEI Industries Limited1.03%$6.72M₹495.02B46.29%
63
Neutral
Glenmark Pharmaceuticals Limited0.95%$6.18M₹605.14B30.16%
53
Neutral
Biocon Limited0.84%$5.46M₹674.94B17.75%
63
Neutral
Radico Khaitan Limited0.81%$5.25M₹462.14B35.73%
65
Neutral
APAR Industries Limited0.80%$5.22M₹584.84B93.18%
74
Outperform
Sona BLW Precision Forgings Ltd.0.80%$5.20M₹364.04B18.25%
74
Outperform

SMIN Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
66.13
Positive
100DMA
65.31
Positive
200DMA
68.10
Negative
Market Momentum
MACD
0.08
Positive
RSI
54.08
Neutral
STOCH
48.95
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMIN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 66.40, equal to the 50-day MA of 66.13, and equal to the 200-day MA of 68.10, indicating a neutral trend. The MACD of 0.08 indicates Positive momentum. The RSI at 54.08 is Neutral, neither overbought nor oversold. The STOCH value of 48.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMIN.

SMIN Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$634.04M0.74%
60
Neutral
$6.62B0.61%
67
Neutral
$545.87M0.65%
68
Neutral
$154.81M0.75%
57
Neutral
$132.08M0.80%
64
Neutral
$129.52M0.78%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SMIN
iShares MSCI India Small Cap ETF
67.09
-6.55
-8.89%
INDA
iShares MSCI India ETF
INDY
iShares India 50 ETF
GIND
Goldman Sachs India Equity ETF
NFTY
First Trust India NIFTY 50 Equal Weight ETF
IMVP
Invesco India Etf
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement